What is the purpose of this trial?
Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.
Ages: 18 - 65 years
Pfizer Inc., U.S. Pharmaceuticals Group
Start Date: 10/15/2015
End Date: 11/30/2019
Last Updated: 02/22/2018
Study HIC#: 1401013207